TRACON Pharmaceuticals (NASDAQ:TCON) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report published on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a neutral rating on shares of TRACON Pharmaceuticals in a research note on Monday, July 1st. Check Out Our Latest Stock Report […]
15 Oct 01:39 · The Cerbat Gem